CEV - (Clinically Extremely Vulnerable)

Technically speaking, no MDS or CMML patients should have issues accessing vaccines or anti-COVID19 medication.

If however, you encounter problems, do point any GPs to the document below, which is a new list identifying exactly and precisely who the highest at risk patients are, in terms of COVID-19 infection. MDS, CMML and transplant patients are all listed.

This is the work of a new UK advisory group, supported by the NHS England RAPID-C19 team.

'The recommendations are to support the deployment of approved medications for treatment or prophylaxis, potentially across a range of scenarios.'

Access to Evushield should therefore be made available, according to the recommendations. Click below to read the report.

(Please note this CEV report is a UK only initiative.)

Defining the highest-risk clinical subgroups upon community infection with SARS-CoV-2 when considering the use of neutralising monoclonal antibodies (nMABs) and antiviral drugs: independent advisory group report - GOV.UK (www.gov.uk)